Your browser doesn't support javascript.
loading
Benznidazole-induced drug reaction with eosinophilia and systemic symptoms syndrome in a patient with human leucocyte antigen (HLA)-A*68.
Lizondo López, Thais; Gil Lianes, Javier; Torrent Rodríguez, Arnau; González-García, Rubén; Tuset Creus, Montserrat; Amat Samaranch, Victoria; Soy-Muner, Dolors; Mascaró, José Manuel.
Afiliación
  • Lizondo López T; Pharmacy Service. Division of Medicines, Hospital Clínic Barcelona, Barcelona, Spain tlizondo@clinic.cat.
  • Gil Lianes J; Dermatological Service, Hospital Clínic Barcelona, Barcelona, Spain.
  • Torrent Rodríguez A; Pharmacy Service. Division of Medicines, Hospital Clínic Barcelona, Barcelona, Spain.
  • González-García R; Pharmacy Service. Division of Medicines, Hospital Clínic Barcelona, Barcelona, Spain.
  • Tuset Creus M; Pharmacy Service. Division of Medicines, Hospital Clínic Barcelona, Barcelona, Spain.
  • Amat Samaranch V; Dermatological Service, Hospital Clínic Barcelona, Barcelona, Spain.
  • Soy-Muner D; Pharmacy Service. Division of Medicines, Hospital Clínic Barcelona, Barcelona, Spain.
  • Mascaró JM; Dermatological Service, Hospital Clínic Barcelona, Barcelona, Spain.
Eur J Hosp Pharm ; 2024 Jan 18.
Article en En | MEDLINE | ID: mdl-38238103
ABSTRACT
Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a rare but severe drug hypersensitivity reaction with potentially life-threatening consequences. It is characterised by fever, extensive maculopapular exanthema, lymph node enlargement, abnormal blood cell counts, and organ-related complications. Diagnosis can be challenging due to incomplete or non-specific symptoms, and it can sometimes manifest as a purely systemic disease. Discontinuation of the causative drug is essential. Treatment may involve corticosteroids and supportive care. Genetic screening for specific markers, such as human leucocyte antigen (HLA)-A*68, A1101, and A2902, can help identify individuals at risk for severe reactions to benznidazole, a drug used to treat Chagas disease. This case report describes the rarity and severity of DRESS syndrome, underscoring the potential benefit of genetic screening to prevent adverse reactions in patients with Chagas disease.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies Idioma: En Revista: Eur J Hosp Pharm Año: 2024 Tipo del documento: Article País de afiliación: España

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies Idioma: En Revista: Eur J Hosp Pharm Año: 2024 Tipo del documento: Article País de afiliación: España